Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression

NCT06975332 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
High-Grade Gliomas
Grade III Astrocytoma
Grade III Glioma

Interventions

RADIATION: Local, targeted therapy with alpha emitter [225Ac]Ac-DOTA-SP (TAT)

Sponsor

Medical University of Warsaw